MEDVF (Medivolve) Days Payable: 30,379.41 (As of Mar. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Medivolve Days Payable?

Medivolve MEDVF -99.00% Days Payable is 30,379.41 as of Mar. 2024.

Medivolve's average Accounts Payable for the three months ended in Mar. 2024 was $6.66 Mil. Medivolve's Cost of Goods Sold for the three months ended in Mar. 2024 was $0.02 Mil. Hence, Medivolve's Days Payable for the three months ended in Mar. 2024 was 30,379.41.

The historical rank and industry rank for Medivolve's Days Payable or its related term are showing as below:

MEDVF's Days Payable is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 64.48
* Ranked among companies with meaningful Days Payable only.

Medivolve's Days Payable declined from Mar. 2023 (95,274.13) to Mar. 2024 (30,379.41). It may suggest that Medivolve accelerated paying its suppliers.

Medivolve Days Payable Historical Data

* Premium members only.

The historical data trend for Medivolve's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medivolve Days Payable Chart

Medivolve Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 191.18 118.64 11,441.11 27,272.62

Medivolve Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 95,274.13 0.00 16,280.07 19,543.23 30,379.41

MEDVF vs DMTKQ, TMO, DHR: Days Payable Comparison

For the Diagnostics & Research subindustry, Medivolve's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medivolve Days Payable vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medivolve's Days Payable distribution charts can be found below:

* The bar in red indicates where Medivolve's Days Payable falls into.


Medivolve Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Medivolve's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (5.75 + 6.504) / 2 ) / 0.082*365
=6.127 / 0.082*365
=27,272.62

Medivolve's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (6.504 + 6.813) / 2 ) / 0.02*365 / 4
=6.6585 / 0.02*365 / 4
=30,379.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 30,379.41 mean?
Medivolve (MEDVF) has a Days Payable of 30,379.41 as of Mar. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medivolve and its competitors.
Is Medivolve's Days Payable too high?
Medivolve's current Days Payable is 30,379.41. The Medical Diagnostics & Research industry median Days Payable is 64.48. Medivolve's value of 30,379.41 is 47014.5% above this industry median.
How does Medivolve's Days Payable compare to DMTKQ and TMO?
Medivolve's Days Payable of 30,379.41 can be compared against companies in the Medical Diagnostics & Research industry. The industry median Days Payable is 64.48. Medivolve's value of 30,379.41 is 47014.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.48, based on 191 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medivolve's current Days Payable of 30,379.41 is 47014.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medivolve and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medivolve's current Days Payable is 30,379.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medivolve stock overvalued right now?
Medivolve (MEDVF) has a current Days Payable of 30,379.41. The current Days Payable is 30,379.41 and 47014.5% above the Medical Diagnostics & Research industry median of 64.48. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medivolve (MEDVF), the current Days Payable is 30,379.41 as of Mar. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medivolve Business Description

Address 198 Davenport Road, Toronto, ON, CAN, M5R 1J2
Medivolve Inc is a healthcare technology and services company. It is engaged in finding and developing disruptive technologies, groundbreaking innovations, and partnerships to help combat COVID-19 and transform human health management. The company operated one reportable segment, the COVID Testing facilities across the United States Of America.